This document provides recommendations on case definition of: routine surveillance; community-based surveillance; contacts persons of Ebola or Marburg cases; and case definitions used by the surveillance.
Since the latest Ebola outbreak was declared on August 1, a total of 115 people have reported symptoms of hemorrhagic fever, including 85 cases that tested positive for Ebola virus disease and 30 probable cases. There have been 77 deaths among those cases.
The World Health Organization (WHO) reports it is continuing to rapidly scale-up its response to the Ebola outbreak in North Kivu and Ituri provinces, including in Oicha, a town difficult to reach because of security concerns.
A critical concern in stemming this outbreak involves the homes of patients. In a typical Ebola outbreak, for every patient that comes in Doctors Without Borders would send a team to their house to decontaminate it, but in the current outbreak many patients live in areas that are too dangerous to travel to.
Seventy-two out of 111 patients who have been infected with the hemorrhagic fever have died, making this outbreak the deadliest in more than a decade in Congo.
Two of the first 16 people to receive an experimental treatment for Ebola have recovered in the current outbreak in North Kivu and Ituri provinces of the Democratic Republic of Congo.
A doctor has become the first probable Ebola case in one of the eastern Democratic Republic of Congo’s high insecurity zones which are dogged by militia violence and hard to access.
Military escorts are helping health workers quell an Ebola outbreak in eastern Democratic of Congo that’s killed 61 people in three weeks.
The Red Cross and Red Crescent are working hard to contain Democratic Republic of Congo’s 10th Ebola outbreak, with a special focus on breaking the deadly virus’ chain of transmission.
The four additional treatments approved by Congo’s ethics committee are Remdesivir, made by Israel’s Gilead Sciences; ZMapp, an intravenous treatment made by San Diego’s Mapp Pharmaceutical; Japanese drug Favipiravir; and one referred to as Regn3450 – 3471 – 3479.